HomeNewsBusinessEconomyExclusive| GST Council: Decision on mode of compensation extension unlikely today

Exclusive| GST Council: Decision on mode of compensation extension unlikely today

Moneycontrol understands that one of the options being given to the states is continuing compensation in lieu of tax shortfall at a much lower rate than the existing 14 percent. It could be 11 percent or lower. It is also learnt that the centre is presenting to states some revenue enhancement measures which will enable them to depend less on the shortfall compensation from the centre.

September 17, 2021 / 18:03 IST
Story continues below Advertisement
Representative image
Representative image

The Goods and Service Tax Council is unlikely to reach a final decision on the ways in which to extend compensation to states beyond June 2022, Moneycontrol has learnt.

It is understood that the centre has given a presentation to states and laid out options on how the compensation can be extended beyond its end-date next year. However, the states are likely to be given time to decide which option suits them best, said an official who is aware of the deliberations in the GST Council meeting.

Story continues below Advertisement

"The centre believes that beyond June 2022, annual compensation of Rs 1 lakh crore should be enough. States believe that more than that is required," said an informed source.

The person added that any decision on either the mode of compensation beyond June 2022 or on inclusion on petroleum products under GST is unlikely today, though the latter topic has also been discussed in the Council meeting.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show